/ Print /

HOSPITAL & PROVIDER STRATEGY

How to prepare for population healthHere’s how to overcome the hurdles that hinder your population health strategies.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Four health systems develop opioid mitigation programsAlternatives to opioids programs emerge as viable tools to mitigate the crisis.
Retail clinic pros and cons: Impact on healthcare spending
Retail clinic pros and cons: Impact on healthcare spendingA new RAND analysis of retail clinics finds they could be increasing healthcare costs.
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Personalized medicine brings big wins to managed careA new report reveals how personalized medicine can make patients healthier while lowering costs.
Top 3 roadblocks to medication adherence and how to avoid themHere are the top three reasons for medication adherence failure and how to overcome them.
Physician shortages may affect population health strategiesBy 2025, the United States could be facing a shortage ranging from 34,600 to 88,000 physicians in total. Find out how this could affect population health initiatives.
Robust multiple myeloma treatment program holds promiseThe Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.